Ipsen announces that its subsidiary Anemone Acquisition Corp has extended the validity period of its tender offer to acquire the shares of Albireo Pharma, until March 1 at 11:59 p.m., U.S. East Coast time, unless further extended.

As a reminder, the tender offer offers a net price of $42 per share, payable to the holder in cash, without interest and after applicable withholding taxes, plus one non-transferable contractual guaranteed value certificate (GVC) per share.

As of 6:00 pm Eastern Time on February 21, approximately 13,229,445 Albireo Pharma shares had been validly tendered to the tender offer and not validly withdrawn, representing approximately 63% of the shares outstanding as of January 20.

Copyright (c) 2023 CercleFinance.com. All rights reserved.